BioSpace News Archive

Business

Meet the Former Pfizer Husband-and-Wife Team Who Founded Biotech TransPharm

The company, which now has 11 personnel, is a CRO focused on infectious disease research.

January 15, 2018
·
2 min read
·
Mark Terry
Business

Ironshore Laid Off Staff, Quietly Closed Down After Christmas

Almost one year after filing a NDA for an ADHD drug and less than one year after announcing it secured $200M in financing, Ironshore Pharma has closed its doors.

January 15, 2018
·
2 min read
·
Alex Keown
Deals

U.S. Asset Manager Wants in On China Biotech Unicorn Innovent Biologics’ $200M+ IPO

The Suzhou-based cancer-drug maker has been discussing a valuation of more than $1 billion.

January 15, 2018
·
1 min read
Policy

Struggling Teva Gets Another Hit, Fined for Foreign Bribes

The fine was over Teva paying bribes to foreign officials to win business in Russia, Ukraine and Mexico, the ministry said.

January 15, 2018
·
1 min read
Hua Medicine to Raise $200M to Support Novel Diabetes Drug

Hua Medicine of Shanghai expects to spend $200M over the next three years on its novel oral diabetes 2 treatment, dorzagliatin.

January 15, 2018
·
1 min read
Drug Development

Why 2018 Could be Alnylam’s Best Year Yet

Some achievements are hard to top.

January 15, 2018
·
1 min read
Policy

Serious Adverse Reactions Lead Tesaro to Update Prescribing Information for Varubi

In clinical trials, the most common adverse reactions reported were neutropenia, hiccups, decreased appetite and dizziness.

January 15, 2018
·
2 min read
·
Alex Keown
Policy

Woman Sues Bayer After Essure Device Leaves Her in Constant Pain

The mom of three is now the seventh Scottish woman to join a group legal action against Bayer.

January 15, 2018
·
1 min read
Business

Alnylam CEO Calls Out Trump’s Alleged Immigration Remarks

This not the first time Maraganore has tweeted his support for the benefits of immigration.

January 15, 2018
·
3 min read
·
Alex Keown
Deals

5 Tasty Takeover Targets for 2018

Many investors and analysts expect that the changes to the corporate tax code will lead to increased merger and acquisition activity in 2018.

January 15, 2018
·
3 min read
·
Mark Terry